Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Joel Gelfand, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States
IPC Board Member

Joel M. Gelfand MD MSCE is a James J. Leyden Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 260 scientific publications, editorials, reviews, and textbook chapters (cited over 18,000 times, H index 60) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s New Investigator Marjorie Bowman Award and the Lady Barbara Colyton’s Award for Autoimmune research, Penn’s Department of Biostatistics and Epidemiology’s epidemiology teaching award, NPF’s inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture and the American Academy of Dermatology’s Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Last Updated: Jan 31, 2022


April Armstrong, MD, MPH
Keck School of Medicine, USC
Studio City, California, United States

Dr. April Armstrong is a Professor of Dermatology and Associate Dean at the University of Southern California (USC). She also serves as Vice-Chair in the dermatology department and leads the psoriasis program at USC.
Dr. Armstrong obtained her medical degree from Harvard Medical School and completed her dermatology residency at Harvard. She also received a Master of Public Health degree from the Harvard School of Public Health. Prior to joining the faculty at the University of Southern California, Dr. Armstrong was Vice-Chair at the University of California Davis and later at the University of Colorado.
Dr. Armstrong’s clinical expertise lies in inflammatory skin diseases, especially psoriasis and atopic dermatitis. She has conducted over 150 clinical trials and published over 350 high-impact articles in scientific journals. She holds multiple leadership positions in professional societies, serving as the Chair of the Medical Board of the National Psoriasis Foundation (NPF), Co-president for the Group in Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), a Councilor for both the International Eczema Council (IEC) and the International Psoriasis Council (IPC), and board director for the American Academy of Dermatology (AAD). Dr. Armstrong has also served on the editorial boards for JAMA Dermatology and the Journal of the American Academy of Dermatology (JAAD).

Last Updated: Apr 05, 2022

Steven Fakharzadeh, MD
Janssen Global Services, LLC
Horsham, Pennsylvania, United States

Dr. Steven Fakharzadeh graduated from Cornell University with a B.A. in Biology and American History, and earned his MD and PhD degrees from the University of Pennsylvania School of Medicine. He completed his internship in Internal Medicine at Barnes Hospital of Washington University and his residency training in Dermatology at the University of Pennsylvania. He was a member of the faculty in the Department of Dermatology at the University of Pennsylvania for 12 years prior to joining Johnson & Johnson in 2008. Steve served as the Dermatology Therapeutic Area Strategic Lead for Janssen US Medical Affairs until August, 2016. He then moved to Janssen’s global organization, where his current role is Head of Global Medical Affairs for Dermatology. He maintains an appointment as Clinical Associate Professor of Dermatology at the University of Pennsylvania, where he continues to teach and see patients.

Last Updated: Mar 18, 2022

Alexis Ogdie, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Dr. Ogdie is Associate Professor of Medicine and Epidemiology in the Perelman School of Medicine. She is also Deputy Director of the Center for Clinical Epidemiology and Biostatistics and Director of the Penn Psoriatic Arthritis and Spondyloarthritis Program. Dr. Ogdie's research program focuses on pharmacoepidemiology and observational studies of psoriatic arthritis, an inflammatory arthritis that affects approximately 25% of patients with psoriasis and approximately 500,000 Americans. The mission of her research program is to improve outcomes in psoriatic arthritis by accelerating diagnosis, increasing the focus on meaningful, patient-centered outcomes, and developing and advancing methods for precision medicine. Areas of expertise include epidemiology and pharmacoepidemiology, biostatistical methods for observational studies (e.g., time to event modeling, prediction modeling), outcome measures (e.g., qualitative and quantitative/psychometric assessment), clinical trial design and more general qualitative methods (e.g., survey, focus group and interview studies).

Last Updated: Mar 31, 2022

Nick Reynolds, BSc, MBBS, MD, FRCP
Newcastle University
Newcastle Upon Tyne, England, United Kingdom

Professor Nick J Reynolds received his dermatology training in Bristol, Ann Arbor, Michigan USA and Newcastle upon Tyne. He was appointed to the Chair of Dermatology, Newcastle University and Honorary Consultant Dermatologist, Royal Victoria Infirmary, Newcastle upon Tyne in 2001. Nick leads a dynamic interdisciplinary research group in Newcastle and his clinical and research interests are focused on inflammatory skin disease (psoriasis and atopic eczema). He was previously Chair of the Research and Steering Committees, British Association of Dermatologists Biologics Registry (BADBIR), Chair of UK TREND (Translational Research Network in Dermatology) and President of the European Society for Dermatological Research (ESDR). In 2019, Nick was selected as a NIHR Senior Investigator and is currently Secretary General and Vice President of the European Dermatology Forum (EDF).

Last Updated: Jul 23, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.